Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Injection Drug Use: later-stage trial registry
3 of 4 indexed Injection Drug Use trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Injection Drug Use: 4 US clinical trials tracked, 3 recruiting.
Injection Drug Use is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Jennifer Havens, running 1 of these trials.
Enrollment posture brief
Registry condition injection-drug-use
OPEN 3 | RECR 75% | LATE 4 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Injection Drug Use lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Injection Drug Use on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Injection Drug Use is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use
University of Alabama at Birmingham
NCT06829238
Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs
Massachusetts General Hospital
NCT07199335
Implementing Low-Barrier HCV Treatment in a Jail Setting
Lifespan
NCT06953479
The Kentucky Viral Hepatitis Treatment Study
Jennifer Havens
NCT03949764
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Injection Drug Use records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Injection Drug Use trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Injection Drug Use page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Injection Drug Use trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Jennifer Havens sponsors the most Injection Drug Use trials on record, review their full trial history before evaluating a specific study. See Jennifer Havens's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Injection Drug Use condition card totals 4 registered trials; most-linked intervention Sofosbuvir/velpatasvir (Epclusa®); top US site state Rhode Island. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.